We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$464M
AUM Growth
+$71.8M
Cap. Flow
+$50.4M
Cap. Flow %
10.87%
Top 10 Hldgs %
6.81%
Holding
1,135
New
445
Increased
136
Reduced
132
Closed
422

Sector Composition

Rank Sector Weight
1 Technology 16.86%
2 Healthcare 13.3%
3 Consumer Discretionary 12.71%
4 Financials 12.36%
5 Industrials 12.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDXG icon
701
MiMedx Group
MDXG
$626M
$106K 0.02%
13,752
-5,866
-30% -$47.1K
PACB icon
702
Pacific Biosciences
PACB
$422M
$100K 0.02%
26,744
+1,056
+4% +$6.18K
BYND icon
703
Beyond Meat
BYND
$288M
$99K 0.02%
+11,961
New +$92K
MRNS
704
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$96.4K 0.02%
+10,663
New +$104K
TK icon
705
Teekay
TK
$975M
$96.1K 0.02%
13,205
-10,964
-45% -$85.9K
BRSP
706
BrightSpire Capital
BRSP
$681M
$94.2K 0.02%
13,678
-14,603
-52% -$102K
INFN
707
DELISTED
Infinera Corporation Common Stock
INFN
$94.1K 0.02%
+15,603
New +$78.3K
BCRX icon
708
BioCryst Pharmaceuticals
BCRX
$2.37B
$94.1K 0.02%
18,518
-523
-3% -$2.94K
CMRC
709
Commerce.com Inc Series 1
CMRC
$224M
$93K 0.02%
13,500
-17,654
-57% -$142K
KGC icon
710
Kinross Gold
KGC
$28.5B
$89.2K 0.02%
+14,544
New +$79.1K
ENVX icon
711
Enovix
ENVX
$862M
$85.8K 0.02%
+12,245
New +$106K
TNYA icon
712
Tenaya Therapeutics
TNYA
$168M
$79.8K 0.02%
+15,251
New +$73K
MRSN
713
DELISTED
Mersana Therapeutics
MRSN
$54.9K 0.01%
+490
New +$48.7K
A icon
714
Agilent Technologies
A
$39.1B
-2,411
Closed -$335K
ABBV icon
715
AbbVie
ABBV
$458B
-4,025
Closed -$624K
ABCB icon
716
Ameris Bancorp
ABCB
$5.89B
-3,893
Closed -$207K
ABT icon
717
Abbott
ABT
$180B
-3,662
Closed -$403K
ACCO icon
718
Acco Brands
ACCO
$369M
-38,052
Closed -$231K
ACHR icon
719
Archer Aviation
ACHR
$3.64B
-33,642
Closed -$207K
ACLX
720
DELISTED
Arcellx
ACLX
-6,521
Closed -$362K
ACVA icon
721
ACV Auctions
ACVA
$1.35B
-11,917
Closed -$181K
ADM icon
722
Archer Daniels Midland
ADM
$41.4B
-21,349
Closed -$1.54M
ADNT icon
723
Adient
ADNT
$1.6B
-20,244
Closed -$736K
ADP icon
724
Automatic Data Processing
ADP
$100B
-1,859
Closed -$433K
AEHR icon
725
Aehr Test Systems
AEHR
$2.48B
-29,998
Closed -$796K

Similar funds

Fox Run Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fox Run Management held 1,135 positions worth $464M, up 18% from $392M the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Fox Run Management deployed $50.4M of net new capital in Q1 2024, opening 445 new positions and adding to 136 existing holdings. Its largest new stake was iShares US Real Estate ETF: 31,900 shares worth $2.87M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was State Street Financial Select Sector SPDR ETF, an estimated $4.4M trimmed.

  • Fox Run Management's largest Q1 2024 buy was iShares US Real Estate ETF: 31,900 shares worth $2.87M.
  • Fox Run Management added most to Ecolab in Q1 2024, an estimated $1.89M increase.
  • Fox Run Management's biggest Q1 2024 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $4.4M.
  • Fox Run Management fully exited Kimberly-Clark in Q1 2024, selling an estimated $2.33M.
  • Fox Run Management's ten largest holdings make up 6.8% of its $464M portfolio in Q1 2024.
  • Fox Run Management opened 445 new positions and closed 422 in Q1 2024.
  • Fox Run Management's portfolio value rose 18% quarter-over-quarter to $464M.

Based on Fox Run Management's 13F filing for Q1 2024, filed 13 May 2024.